U.S. markets close in 1 hour 9 minutes

Horizon Therapeutics Public Limited Company (HZNP)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
91.01+1.22 (+1.36%)
As of 2:51PM EDT. Market open.
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 4/12/2021
Current
12/31/20209/30/20206/30/20203/31/2020
Market Cap (intraday) 5
20.50B16.19B17.14B11.09B5.64B
Enterprise Value 3
19.41B15.45B17.58B11.69B5.91B
Trailing P/E
50.5418.4729.6518.4010.21
Forward P/E 1
19.80N/AN/A30.8616.45
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/A
Price/Sales (ttm)
8.959.0610.838.474.68
Price/Book (mrq)
5.094.267.265.072.58
Enterprise Value/Revenue 3
8.8220.7327.6225.2516.60
Enterprise Value/EBITDA 7
26.2049.7561.80122.77117.08

Trading Information

Stock Price History

Beta (5Y Monthly) 1.13
52-Week Change 3184.51%
S&P500 52-Week Change 345.04%
52 Week High 396.54
52 Week Low 330.40
50-Day Moving Average 388.86
200-Day Moving Average 379.79

Share Statistics

Avg Vol (3 month) 32M
Avg Vol (10 day) 31.2M
Shares Outstanding 5224.13M
Implied Shares Outstanding 6N/A
Float 220.8M
% Held by Insiders 11.35%
% Held by Institutions 191.74%
Shares Short (Mar 14, 2021) 45.52M
Short Ratio (Mar 14, 2021) 42.98
Short % of Float (Mar 14, 2021) 42.54%
Short % of Shares Outstanding (Mar 14, 2021) 42.46%
Shares Short (prior month Feb 11, 2021) 46.54M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Dec 30, 2020

Profitability

Profit Margin 17.71%
Operating Margin (ttm)24.09%

Management Effectiveness

Return on Assets (ttm)6.31%
Return on Equity (ttm)12.55%

Income Statement

Revenue (ttm)2.2B
Revenue Per Share (ttm)10.79
Quarterly Revenue Growth (yoy)105.00%
Gross Profit (ttm)1.67B
EBITDA 554.45M
Net Income Avi to Common (ttm)389.8M
Diluted EPS (ttm)1.81
Quarterly Earnings Growth (yoy)-67.90%

Balance Sheet

Total Cash (mrq)2.08B
Total Cash Per Share (mrq)9.28
Total Debt (mrq)1.05B
Total Debt/Equity (mrq)26.10
Current Ratio (mrq)3.51
Book Value Per Share (mrq)18.19

Cash Flow Statement

Operating Cash Flow (ttm)555.69M
Levered Free Cash Flow (ttm)305.13M